Retrospective Observational Study of Implant-supported Restorations With Dental Implants.

NCT ID: NCT06154057

Last Updated: 2024-03-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-01-01

Study Completion Date

2024-07-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This retrospective study aims to value the bone loss and the success and survival of the dental implants produced by additive manufacturing installed in an area grafted with Plenum® Osshp (synthetic bone graft). In addition, the biological and biomechanical performance of implant restorations supported through an observational retrospective solution will be observed. From 50 to 100 survey participants will be selected, who will be invited to attend the clinic for clinical, radiographic, and prosthetic evaluation and successful parameters between baseline, 3, 6, and 12 months. The data obtained regarding bone loss (primary outcome) of the analyzed regions and implant success and survival in area grafted with Plenum® Osshp (secondary outcome) will be evaluated by the paired t-test for the evaluation of the times (3, 6, and 12 months) and survival curves of the installed dental implants.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Oral Surgical Procedures

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Dental Implants installed in an grafted area (sinus lifting)

Dental implants produced by additive manufacturing installed in an area grafted with synthetic bone graft (Plenum® Osshp) - sinus lifting.

Group Type EXPERIMENTAL

Dental Implants installed in an grafted area (sinus lifting)

Intervention Type PROCEDURE

The patient will be invited to participate in the clinic to assess radiographic bone loss and clinical follow-up for 12 months.

Dental Implants installed in an grafted area (ridge augmentation)

Dental implants produced by additive manufacturing installed in an area grafted with synthetic bone graft (Plenum® Osshp) - ridge augmentation.

Group Type EXPERIMENTAL

Dental Implants installed in an grafted area (ridge augmentation)

Intervention Type PROCEDURE

The patient will be invited to participate in the clinic to assess radiographic bone loss and clinical follow-up for 12 months.

Dental Implants installed in an grafted area (extraction sites)

Dental implants produced by additive manufacturing installed in an area grafted with synthetic bone graft (Plenum® Osshp) - extraction sites (socket preservation or dental implant preparation/placement).

Group Type EXPERIMENTAL

Dental Implants installed in an grafted area (extraction sites)

Intervention Type PROCEDURE

The patient will be invited to participate in the clinic to assess radiographic bone loss and clinical follow-up for 12 months.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dental Implants installed in an grafted area (sinus lifting)

The patient will be invited to participate in the clinic to assess radiographic bone loss and clinical follow-up for 12 months.

Intervention Type PROCEDURE

Dental Implants installed in an grafted area (ridge augmentation)

The patient will be invited to participate in the clinic to assess radiographic bone loss and clinical follow-up for 12 months.

Intervention Type PROCEDURE

Dental Implants installed in an grafted area (extraction sites)

The patient will be invited to participate in the clinic to assess radiographic bone loss and clinical follow-up for 12 months.

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

maxillary sinus lift Guided bone regeneration Guided bone regeneration

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Clinical parameters:

* Presence or absence of pain or tenderness
* Presence or absence of suppuration or exudation
* Presence or absence of mobility

Prosthetic parameters

\- Presence or absence of mechanical complications (problems in prefabricated components such as screws and abutments).

Radiographic Parameters

* Presence or absence of peri-implant radiolucidity.
* maintenance and quality of the bone graft volume in the grafted area to each clinical indication: ridge augmentation, extraction sites (socket preservation or dental implant preparation/placement) and sinus lifting.
* Distance between the shoulder of the implant and the first visible bone contact (in mm).
* Presence or absence of technical complications such as fracture or loss of porcelain structures.

Success Parameters

* Absence of pain or tenderness.
* Absence of suppuration or exudation.
* Clinical absence of implant mobility.
* Absence of peri-implant radiolucency.
* Minor loss of up to 1.5mm in the first year of function.
* Absence of mechanical or technical complications in the dental implant and in the prosthesis to the dental implants installed in an area grafted.

Exclusion Criteria

* N/A
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Guarulhos

OTHER

Sponsor Role collaborator

M3 Health

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jamil A Shibli, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Guarulhos, UnG

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Guarulhos

Guarulhos, São Paulo, Brazil

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Brazil

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Plenum Oss 002

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.